The QualityStocks Daily Thursday, October 4th, 2018

Today's Top 3 StockMarketWatch

MarketClub Analysis (VXRT) +88.85%

StockMarketWatch (IAM) +56.38%

BUYINS.NET (HSGX) +51.52%

The QualityStocks Daily Stock List

Digerati Technologies, Inc. (DTGI)

Emerging Growth, Real Investment Advice, Wallet Investor, OTCPicks, AllPennyStocks, MicrocapVoice, Equities, Marketwired, SmallCapVoice and Stockopedia reported on Digerati Technologies, Inc. (DTGI), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Digerati Technologies, Inc. is a diversified holding company based in San Antonio, Texas. It has subsidiary operations in the cloud communications industry. The Company, through its wholly-owned subsidiary, Shift8 Technologies, Inc., provides Internet-based telephony products and services by way of its cloud telephony application platform and session-based communication network. Digerati Technologies lists on the OTCQB.

In essence, Digerati Technologies is an established and award-winning provider of cloud communication services. It serves traditional carriers, telephony resellers, and other VoIP (Voice over Internet Protocol) carriers in the U.S. and internationally. The Company provides VoIP communication services to telecommunications enterprises.

The Company’s Shift8 Networks subsidiary is an enterprise hosted PBX and cloud-based Unified Communications service provider. Shift8 Networks provides voice, video, and mobile communications to thousands of businesses through its Channel Alliance program. Shift8 integrates hosted VoIP with cloud-based messaging and desktop applications. Shift8's VAR program targets PBX Vendors, Information Technology (IT) Services firms, Managed Service Providers, and Systems Integrators that lack a cloud telephony infrastructure, but have an embedded customer base that necessitates Internet-based telephony services.

Additionally, Digerati Technologies provides Internet-based services. These include fully hosted IP/PBX services, IP trunking; call center applications, prepaid services, and interactive voice response auto attendant. Also, services include call recording, simultaneous calling, voicemail to email conversion, and manifold customized IP/PBX features in a hosted or cloud environment for specialized applications.

In 2017, Digerati Technologies completed the acquisition of Synergy Telecom, Inc. Digerati’s Shift8 Networks combined Synergy Telecom with its Texas-based business and operations. Synergy Telecom is a top provider of cloud communication services in Texas.

Digerati also completed the acquisition of T3 Communications, Inc. in 2018. It stated that this acquisition positions Digerati Technologies for hyper-growth in two of the fastest growing sectors of the telecommunications industry, UCaaS (Unified Communications as a Service) and SD-WAN (Software-Defined Wide-Area Network). T3 Communications is a leading provider of cloud communications and broadband solutions in Southwest Florida.

Last week, Digerati Technologies announced that it launched a mobile ‘business continuity’ solution in partnership with Otarris, a division of Kajeet, Inc., for addressing the growing demand for disaster recovery networks in the enterprise marketplace. The Company is addressing the growing need for its customers to deploy a redundant and varied bandwidth solution for ‘business continuity’ during primary network outages. These include those caused by natural or human-induced disasters.

Digerati Technologies will offer its wireless solution via its operating subsidiaries Synergy Telecom and T3 Communications. Its wireless solution will be marketed mainly as a back-up solution. However, Digerati will sell its wireless service as a primary network to customers with limited access to a reliable broadband network.

Digerati Technologies, Inc. (DTGI), closed Thursday's trading session at $0.279, up 16.30%, on 25,000 volume with 6 trades. The average volume for the last 3 months is 7,228 and the stock's 52-week low/high is $0.165/$0.85.

chart

Cannabis Sativa, Inc. (CBDS)

Real Pennies, Marketbeat, TopStockAnalysts, TheMicrocapNews, Stock Beast, Promotion Stock Secrets, Top Pros’ Top Picks, Insider Financial, Wall Street Mover, Flagler Financial Group, Jason Bond, TopPennyStockMovers, Stockgoodies, Cannabis Financial Network News, Greenbackers, and smartOTC reported on Cannabis Sativa, Inc. (CBDS), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Cannabis Sativa, Inc. engages in branding and licensing through its 'hi' intellectual properties. The Company engages, through its subsidiaries, Wild Earth Naturals and "hi" Brands International, Inc., in the research, development, and licensing of specialized natural products. These include formulas, edibles, topicals, recipes, and delivery systems. Cannabis Sativa has been active in pursuing Intellectual Property (IP). The Company has successfully acquired a growing portfolio of IP. Cannabis Sativa is based in Mesquite, Nevada.

The Company brands, licenses, innovates, and markets premier plant-derived topical creams, transdermals, balms, sublinguals, lubricants, and edibles for medical and recreational marijuana consumers, and legal nutraceuticals and branded merchandise for consumers in general. Cannabis Sativa holds a U.S. patent on the Ecuadorian Sativa strain of Cannabis. In addition, it owns patent pending and trade secret formulas and processes.

hi Brands International entered into an agreement with Centuria Natural Foods, Inc. to market their proprietary CBD Rich Hemp Oil products. Their CBD capsules are marketed under the name, "hi CBD."

Cannabis Sativa has its Wild Earth Naturals offerings. It offers the Wild Earth Naturals line of CBD Water and cosmetic products designed to use organic and natural ingredients. These include CBD and hemp seed oil.

Cannabis Sativa entered into a license agreement for the manufacture, marketing, and sale of its White Rabbit products in California. It closed its acquisition of the White Rabbit brand of cannabis sprays and cannabis mints.

Moreover, the Company acquired a majority ownership interest in iBudtender, Inc., a Colorado corporation. It also entered into an agreement to acquire a 49 percent ownership interest in a nine-acre property in Los Angeles County, California. The ownership group’s intention is to lease the property to an industrial hemp farm operator.

Cannabis Sativa acquired a controlling interest in PrestoCorp (a.k.a. PrestoDoctor). This online telemedicine platform provides access to knowledgeable physicians for a safe and confidential way to get a medical marijuana recommendation employing secure video conferencing technology.

Recently, Cannabis Sativa subsidiary PrestoDoctor announced that it is now providing online medical marijuana recommendations to Pennsylvania residents through its HIPPA compliant trusted online recommendation platform https://Prestodoctor.Com/. PrestoDoctor makes the process simple and seamless. It does so by providing the state required two doctor appointments completely online. This permits patients to speak to licensed compassionate physicians who specialize in medical marijuana evaluations.

Kyle Powers, Chief Executive Officer, said, "Easier access to alternative care is the driving mission at Presto Doctor, and has made PrestoDoctor the #1 rated online medical marijuana recommendation platform. We are committed to serve patients in Pennsylvania with the integrity we have displayed in California, Nevada and New York."

Cannabis Sativa, Inc. (CBDS), closed Thursday's trading session at $5.16, up 1.78%, on 81,681 volume with 357 trades. The average volume for the last 3 months is 245,214 and the stock's 52-week low/high is $1.915/$9.74.

chart

International Frontier Resources Corporation (IFRTF)

4-Traders, MarketWatch, Stockhouse, Marketwired, and Emerging Growth reported on International Frontier Resources Corporation (IFRTF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

International Frontier Resources Corporation has a demonstrated record of accomplishment advancing oil and gas projects. The Company, through its Mexican subsidiary, Petro Frontera S.A.P.I de CV and strategic joint ventures (JVs) is advancing the development of petroleum and natural gas assets in Mexico. OTCQB-listed, International Frontier Resources is headquartered in Calgary, Alberta.

International Frontier Resources (IFR) has projects in the United States and Canada. This includes the State of Montana and the Northwest Territories. IFR formed a JV company in 2015 - Tonalli Energia - together with Grupo Idesa, one of Mexico’s largest petrochemical companies. IFR and Grupo Idesa are completely aligned; each owns a 50 percent stake in Tonalli. Grupo Idesa is a well-established Mexican petrochemical company.

Block 24 Tecolutla establishes IFR’s Mexican JV as one of the first operators’ in Mexico. Furthermore, it provides vital insights into future rounds. Tecolutla is a very underdeveloped mature field with significant upside potential. The Tecolutla Block is in the Tampico-Misantla Basin within the State of Veracruz.

The Tecolutla Field is 7.2 square kilometers. It contains an oil reservoir at 2,340 meters or roughly 7,700 feet. The Tecolutla Block is a 60-80 m gross pay carbonate reservoir on a structural high with proven oil production.

Tonalli has submitted the regulatory applications and documentation that will allow IFR to go ahead with the drilling permit and operations at Tecolutla. The expectation is that the existing wells at Tecolutla will surpass historic production numbers and peak initial production (IP) rates with the arrival of new recovering techniques, technology, as well as expertise to be undertaken by Tonalli.

In mid-September, IFR announced that its JV Tonalli Energia started trucking of oil produced at its Tecolutla block for sale to PEMEX. Oil produced during the well testing phase is being trucked to PEMEX’s Ezequiel Ordonez facility, roughly 35 kilometers from the Tecolutla block. Tonalli recently entered into a crude oil commercialization agreement with PEMEX.

In addition, in September, IFR announced that it entered into a share option agreement with its JV partner, Grupo IDESA, S.A de C.V. (IDESA). With this agreement, IFR’s wholly-owned Mexican subsidiary, Petro Frontera, S.A.P.I. de C.V. was granted the option to purchase all of the outstanding shares in the JV company, Tonalli Energia S.A.P.I. de C.V. (Tonalli) held by IDESA. Tonalli holds the license contract for onshore oil and gas development Block 24, the Tecolutla Block, in Veracruz, Mexico.

International Frontier Resources Corporation (IFRTF), closed Thursday's trading session at $0.11408, up 2.31%, on 32,000 volume with 13 trades. The average volume for the last 3 months is 60,785 and the stock's 52-week low/high is $0.078/$0.2865.

chart

Acorn Energy, Inc. (ACFN)

MegaPennyStocks, Catalyst IR, Wall Street Resources, Wealthpire, SmarTrend Newsletters, Marketbeat, and Hit and Run Candle Sticks reported on Acorn Energy, Inc. (ACFN), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Acorn Energy, Inc. is a provider of machine-to-machine, Internet of Things (IoT) remote monitoring and control systems and services. Acorn has its portfolio company - OmniMetrix™, Inc. The Company has an 80 percent equity stake in OmniMetrix.  Acorn Energy is a provider of high growth, wireless remote monitoring and control (IoT) services for critical industrial assets (generators, pipelines and other industrial assets). OTCQB-listed, the Company is headquartered in Wilmington, Delaware. 

Acorn Energy’s OmniMetrix™ remotely monitors emergency back-up power generation systems to increase their reliability. OmniMetrix™ is the leader and innovator in M2M wireless remote monitoring, control and diagnostics for pipelines and critical equipment.

OmniMetrix is a solution for making critical systems more reliable. The Company is a solution for pipelines and critical facilities internationally. This includes cell towers, medical facilities, data centers, public transportation systems, and federal, state, and municipal government facilities.

Acorn Energy has sold its DSIT Solutions interest. Acorn secured right of first negotiation to act as exclusive distributor for DSIT's new fiber-optic sensor technology for pipeline monitoring and control in the United States. Acorn Energy completed the sale of its remaining DSIT (Israel based) interest in February.

This technology offers a new range of high-value service opportunities, including monitoring for third party intervention or gas or oil leaks, to complement and expand Acorn Energy's existing OmniMetrix pipeline monitoring business, which currently provides cathodic or corrosion protection systems on gas pipelines to utilities and pipeline companies.

Recently, Acorn Energy announced results for its Q1 ended March 31, 2018.

Mr. Jan Loeb, Acorn Energy President and Chief Executive Officer, said, "We demonstrated solid operating progress in the first quarter with new orders increasing 12 percent and revenue rising 10 percent versus a year ago, in what is generally our seasonally slowest selling period. We were also successful in expanding our gross margin to 62 percent from 56 percent in the first quarter of 2017, generating a 21 percent increase in Gross Profit. Our OmniMetrix industrial monitoring and control subsidiary trimmed its operating loss to $55,000 in the first quarter from $196,000 in the first quarter of last year.”

Last month, Acorn Energy announced the hiring of Ms. Tracy Clifford, CPA as Chief Financial Officer (CFO) of the Company. Ms. Clifford succeeds former CFO Michael Barth, who served Acorn Energy through DSIT Solutions. Ms. Clifford formerly served as CFO, Principal Accounting Officer, Corporate Controller and Secretary for a publicly-traded pharmaceutical company and a publicly-traded REIT from 1999 to 2015.

Acorn Energy, Inc. (ACFN), closed Thursday's trading session at $0.28, up 1.73%, on 10,202 volume with 5 trades. The average volume for the last 3 months is 28,120 and the stock's 52-week low/high is $0.149/$0.449.

chart

Provectus Biopharmaceuticals, Inc. (PVCT)

The Street, Streetwise Reports, AllPennyStocks, Stock News Now, Seeking Alpha, TopPennyStockMovers, StreetInsider, TopStockAnalysts, plrinvest, Investors Underground, Real Pennies, PennyStocks24, Club Penny Stocks Network, StreetAuthorityDaily, TheMicrocapNews, and Wise Alerts reported previously on Provectus Biopharmaceuticals, Inc. (PVCT), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Provectus Biopharmaceuticals, Inc. is a clinical-stage oncology and dermatology Biopharmaceutical Company. It is developing new therapies for the treatment of solid tumor cancers and dermatologic diseases. It’s investigational oncology drug is PV-10. PV-10 is an oncolytic immunotherapy enrolling patients in Phase 3 clinical trials for metastatic melanoma. Provectus Biopharmaceuticals has its corporate office in Knoxville, Tennessee. The Company lists on the OTCQB.

PV-10 is an ablative immunotherapy under investigation in solid tumor cancers. PH-10 is a topical investigational drug for dermatology. It is undergoing clinical testing for atopic dermatitis and psoriasis.

Provectus Biopharmaceuticals completed Phase 2 trials of PV-10 as a therapy for metastatic melanoma, and of PH-10 as a topical treatment for atopic dermatitis and psoriasis. The intention of PV-10 is to kill only diseased cells upon injection into tumors. The Company has received orphan drug designations from the Food and Drug Administration (FDA) for its melanoma and hepatocellular carcinoma indications.

PV-10 is a 10 percent solution of small molecule and halogenated xanthene Rose Bengal. It undergoes administration through direct injection into solid tumor cancers, such as melanoma, liver, and breast. It is not designed to rely on a single pathway, receptor or antigen to work. There is no known resistance.

PH-10 is a topical hydrogel formulation. It yields selective delivery of rose bengal disodium to epithelial tissues. Pertaining to PH-10 for psoriasis and atopic dermatitis, a mechanism of action study is underway to measure the clinical and cellular response to PH-10's active investigational agent. A total of 226 subjects have been treated with PH-10 in Phase 1 or Phase 2 Clinical Trials.

Last month, Provectus Pharmaceuticals announced the completion of enrollment of 24 patients with metastatic melanoma into the Phase 1b portion of its Phase 1b/2 study of intralesional (IL) PV-10 in combination with KEYTRUDA® (pembrolizumab). This is Merck & Co.'s systemic anti-PD-1 (programmed death receptor-1) antibody (ClinicalTrials.gov identifier: NCT02557321). The study's endpoints include those presently suitable for a registration trial.

Last week, Provectus Pharmaceuticals announced that the Indian Patent Office (IPO) granted the Company’s patent application for the synthetic process used to produce the active pharmaceutical ingredient (API) in PV-10, Provectus’ lead investigational oncology drug. The Company’s patent estate associated with API manufacturing provides intellectual property (IP) protection in several nations in Asia, Europe, and North America into the 2030’s.

Provectus Biopharmaceuticals, Inc. (PVCT), closed Thursday's trading session at $0.0711, up 2.23%, on 132,107 volume with 14 trades. The average volume for the last 3 months is 218,131 and the stock's 52-week low/high is $0.025/$0.092.

chart

Thunder Mountain Gold, Inc. (THMG)

FeedBlitz, Zacks, and MarketWatch reported on Thunder Mountain Gold, Inc. (THMG), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Thunder Mountain Gold, Inc. is a junior gold exploration company listed on the OTCQB. The Company owns interests in many U.S. precious metals projects. Its principal asset is The South Mountain Project. The South Mountain Project is on private and patented land in southern Idaho, just north of the Nevada border. Established in 1935, Thunder Mountain Gold is based in Boise, Idaho.

The Company also has its Trout Creek Project. The Trout Creek target is in the Reese River Valley area south of Battle Mountain, Lander County, Nevada. This is a grass roots gold target in the Eureka-Battle Mountain trend of central Nevada, now under Joint Exploration Agreement with Newmont USA Limited. This target comprises 60 unpatented lode mining claims.

Thunder Mountain Gold’s other projects include Clover Mountain. The Company controls 40 unpatented lode mining claims encompassing roughly 800 acres, near Clover Mountain in Owyhee County, Idaho. Furthermore, its West Tonopah Property consists of 8 unpatented lode mining claims totaling 160 acres in the Tonopah Mining District, Esmeralda County, Nevada.

Thunder Mountain Gold owns 100 percent of the above-mentioned South Mountain Mine. This mine has a land package consisting of roughly 1,200 acres of mostly private land - both owned outright and leased. In 2009, a new gold discovery was revealed during fieldwork at South Mountain. The Company’s plan of operation for this, subject to business conditions, is to continue to advance the development at the South Mountain Project.

The flagship South Mountain Project remains Thunder Mountain Gold’s focus. The primary metals at South Mountain are silver, zinc, lead, copper, and gold.

In June, Thunder Mountain Gold announced that it filed a new National Instrument 43-101 (NI 43-101) Technical Report, which included a new mineral resource estimate on the South Mountain Project. The Technical Report has an effective date of April 7, 2018. The most recent Thunder Mountain Gold drilling program was successful in defining the geometry and confirming the grades of the DMEA and Texas massive sulfide zones.

Hard Rock Consulting, LLC (HRC) of Lakewood, Colorado completed the Technical Report for the Company`s South Mountain Project. HRC concludes that major potential exists to increase the known mineral resource with additional drilling, and to upgrade existing mineral resource classifications with additional infill drilling.

Thunder Mountain Gold, Inc. (THMG), closed Thursday's trading session at $0.12, up 20.00%, on 5,000 volume with 1 trade. The average volume for the last 3 months is 7,579 and the stock's 52-week low/high is $0.079/$0.219.

chart

eWellness Healthcare Corp. (EWLL)

Penny Stock Tweets, Investors Hangout, Capital Cube, InvestorsHub, Stockhouse, StockHideout, Penny Stock Prodigy, Emerging Growth and 4-Traders reported on eWellness Healthcare Corp. (EWLL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

eWellness Healthcare Corp. develops a telemedicine platform. This platform is for providing Distance Monitored Physical Therapy programs. The programs are for pre-diabetic, cardiac, and health challenged patients through contracted physician practices and healthcare systems. eWellness Healthcare has its corporate office in Culver City, California.

eWellness Healthcare has launched PHZIO. The design of this Physical Therapy Telemedicine platform is to extend and scale a physician’s practice. The Company is the first physical therapy telemedicine enterprise to provide insurance reimbursable real-time distance monitored treatments.  

PHZIO extends a traditional practice online. The main features of the PHZIO platform include video treatment protocols, real-time patient monitoring, patient induction forms, a patient video journal, and post treatment evaluations. In addition, main features include integrated billing, patient metrics, and user administration & customization. PHZIO also scales a practice’s billable rates and provides tools to make developing a business easier.

Concerning the Patient Dashboard, the PHZIO Dashboard permits clients to login securely to access prescribed treatment protocols. PHZIO is user-friendly and highly reliable to operate for PT and Patient. Furthermore, it is a complete on-line PT telemedicine intervention system.

eWellness Healthcare’s business model is to license the PHZIO platform to any Physical Therapy (PT) clinic in the United State and/or have large-scale employers use its PHZIO platform as a totally PT monitored corporate wellness program. The Company has launched its new patient lead generation platform, LeadRemedy.com. Lead Remedy increases a Practices’ social networks reach through tapping into the employees of the practice and their social circles.

In August, eWellness Healthcare announced that it is continuing to develop the first tokenized physical therapy payment system for insurance companies, large scale self-insured corporations and their insured members. Fintech Global Consultants (FGC) is assisting eWellness in completing the Blockchain and tokenized payment system.

Earlier this week, eWellness Healthcare announced that its Chief Executive Officer, Mr. Darwin Fogt, sold all of Evolution Physical Therapy clinics in order to exclusively concentrate on the expansion and success of eWellness. Mr. Fogt stated, “I have just completed the sale of all of my Evolution Physical Therapy clinics, so that I can solely focus on becoming the industry thought leader in the new realm of digital telehealth physical therapy (dPT).

Moreover, this week, eWellness Healthcare announced that it is doubling down on its partnership and sales efforts to the workman’s compensation industry. Mr. Fogt stated, “ We have now created a strong path to initial revenue generation and substantial sales growth through executing on our Workers Compensation Sales Funnel. Our Workman’s Compensation Sales Funnel currently includes 101 companies.”

eWellness Healthcare Corp. (EWLL), closed Thursday's trading session at $0.114, up 1.33%, on 529,859 volume with 56 trades. The average volume for the last 3 months is 602,062 and the stock's 52-week low/high is $0.045/$0.192.

chart

Novo Integrated Sciences, Inc. (NVOS)

OTC Markets, Stock Orange, InvestorPlace InvestorsHub, Corporate Information, Simply Wall St, TradingView, Stockhouse, MarketWatch, and Investing News Alerts reported on Novo Integrated Sciences, Inc. (NVOS), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Novo Integrated Sciences, Inc. is a provider of multi-disciplinary primary healthcare services and products in Canada by way of its wholly-owned Canadian subsidiary Novo Healthnet Limited (NHL). The Company’s mission is to build a United States and Canadian based multi-disciplinary primary healthcare service provider, which provides premier specialized healthcare services and products via the integration of technology and medical science. OTCQB-listed, Novo Integrated Sciences has its corporate office in Bellevue, Washington.

Novo Healthnet Limited (NHL) - directly and indirectly, through its contractual relationships - provides its specialized services to greater than 300,000 patients each year. The Novo Family's services include pain assessment, treatment, management, and also prevention. These are provided in corporate owned clinics, homes, as well as institutional locations across Canada.

NHL owns a 100 percent stake in Novo Assessments, Inc., Novo Healthnet Rehab Limited, Novo Peak Health, Inc., and an 80 percent stake in Novo Healthnet Kemptville Centre, Inc. All of these are Province of Ontario companies.

Novo Integrated Sciences’ multi-disciplinary primary healthcare services and protocols are directed at assessment, treatment, management, rehabilitation and prevention through its 14 corporate owned clinics, 86 affiliate clinics, 9 retirement homes and over 130 long-term care facilities throughout Canada.

The Novo Family provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, and massage therapy. In addition, it provides acupuncture, chiropodist, neurological functions, kinesiology, certain dental assessments, certain long-term care services, and other para-medical services to its clients.

In March 2018, Novo Integrated Sciences, by way of its wholly-owned U.S. based subsidiary, Novomerica Health Group, Inc., a Nevada corporation, announced a signed Letter of Intent (LOI) to acquire Illinois Spine and Disc Institute, Ltd. (ISDI) and Progressive Health and Rehabilitation, Ltd. Both of these entities are Illinois based medical care corporations dedicated to the diagnosis, treatment and rehabilitation of peripheral neuropathy related spine and neck disorder.

Novo Integrated Sciences, Inc. (NVOS), closed Thursday's trading session at $1.41, down 30.88%, on 43,417 volume with 62 trades. The average volume for the last 3 months is 31,718 and the stock's 52-week low/high is $0.1135/$2.99.

chart

American Cannabis Company, Inc. (AMMJ)

Wall Street Daily, Promotion Stock Secrets, CFN Media Group, The Street, Marketbeat, Cannabis Financial Network News, Stock News Now, Wealth Insider Alert, Market Intelligence Central, and TheOTCInvestor reported on American Cannabis Company, Inc. (AMMJ), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

American Cannabis Company, Inc. is a full-service Business-to-Business (B2B) consulting solutions provider. It is also a seller of ancillary products to the cannabis industry. The Company provides end-to-end solutions to existing and ambitious participants in the cannabis industry. American Cannabis supports its clients from concept to creation, commercialization and continuing operations. American Cannabis Company has its head office in Denver, Colorado.

The Company provides complete consulting management and products solutions to the regulated cannabis markets. It uses its industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure, and establish operational best practices.

American Cannabis has its proprietary product called SoHum Living Soils™. SoHum Living Soils™ is a proprietary "just add water" growing medium. It contains 100 percent natural ingredients. SoHum Living Soils™ provides the plant a complete buffet of macro/micro nutrients to realize genetic optimization of the cannabis plant.

The Company also owns The Cultivation Cube™, and The High Density Cultivation System™. These are proprietary cultivation products.

Regarding Consulting, American Cannabis provides application support, business planning, site selection, and regulatory compliance, among other services. Pertaining to Management, the Company provides yield analysis, staffing, business coaching, and staff training and education, and more.

Concerning Products, American Cannabis provides a comprehensive organic grow system, retail solutions (the Satchel™), and grow components. In addition, it provides group purchasing discounts for supplies. The Satchel is a child-proof, tamper-proof vessel for dispensaries. The Satchel™ may be used by dispensaries to assemble orders and ensure the proper post sale handling of cannabis per each State's legislation.

American Cannabis has secured a consulting contract with Cloud 9 Apothecary in California. In association with the consulting agreement, it will acquire an equity stake in Cloud 9’s project that is now non-operational and in the development stage.

The project will comprise a closed-loop greenhouse containing a 22,000 square foot canopy of premium cannabis cultivars. This project will be built-out and completed in Desert Springs, California.

American Cannabis Company, Inc. (AMMJ), closed Thursday's trading session at $0.532, up 0.38%, on 108,671 volume with 104 trades. The average volume for the last 3 months is 163,685 and the stock's 52-week low/high is $0.389/$1.53.

chart

ARC Group, Inc. (ARCK)

Zacks, MarketWatch, Stockhouse, YCharts, OTC Markets, InvestorsHub, Capital Cube, Barchart, Insider Monkey, GuruFocus, 4-Traders, and The Street reported on ARC Group, Inc. (ARCK), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

ARC Group, Inc. is the owner, operator, and franchisor of the Dick’s Wings & Grill concept. Dick’s Wings has 15 restaurants in Florida and five restaurants in Georgia. Dick's Wings is actively offering franchise opportunities in Florida, Georgia, Alabama, Louisiana, North Carolina and South Carolina. Dick’s Wings & Grill® restaurants provides its customers a casual, family-fun restaurant environment designed to appeal to families and sports fans alike.

Established in 2000, ARC Group is based in Jacksonville, Florida. The Company lists on the OTC Markets Group’s OTCQB.

Dick’s Wings features its award-winning chicken wings, hog wings, and duck wings spun in its signature sauces and seasonings. Moreover, it offers its own proprietary line of craft beers under the name “Dick’s Craft Beers”. Dick's Wings offers an array of boldly-flavored menu items. These are highlighted by its award-winning, Buffalo, New York-style chicken wings and hog wings and its Dick's Blingz® boneless chicken wings in 365 flavors.

Dick’s Wings also offers customers an assortment of fresh sandwiches, burgers, wraps, salads, and signature waffle fries. The restaurants are an elevated sports-themed environment. They include flat screen TVs positioned throughout each facility and children's areas filled with video games and other types of children's entertainment.

ARC Group announced in July that it intends to acquire Tilted Kilt Pub & Eatery®. ARC Group and the owners of Tilted Kilt started to execute agreements for the sale of Tilted Kilt to SDA Holdings, LLC, a company owned by Mr. Fred W. Alexander, who is a member of the Board of Directors of ARC Group. ARC Group intends to enter into an agreement with SDA Holdings to acquire Tilted Kilt from SDA Holdings.

Last month, ARC Group announced that it completed the acquisition of the Fat Patty’s® franchise. ARC Group acquired all of the assets of Fat Patty’s for a purchase price of $12.3 million. In 2017, the Fat Patty’s franchise generated greater than $11 million in Revenue and $700,000 in Net Income. Fat Patty’s has four locations in operation in West Virginia and Kentucky.

ARC Group, Inc. (ARCK), closed Thursday's trading session at $1.69, even for the day, on 2,000 volume with 2 trades. The average volume for the last 3 months is 931 and the stock's 52-week low/high is $0.9425/$2.25.

chart

Bemax, Inc. (BMXC)

Penny Stock Tweets, Stock Guru, Penny Investor Network, StockRockandRoll, PennyStockLocks, Insider Financial, and ResearchOTC reported on Bemax, Inc. (BMXC), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, Bemax, Inc. is a growing worldwide distributor of Disposable Baby Diapers. It exports and distributes Disposable Baby Diapers from the U.S. to developing markets in Africa and Europe. Additionally, the Company exports its private label brands from manufacturers in Asia and distributes to other growing markets. Formed in 2012, Bemax is headquartered in Dallas, Georgia.

The Company focuses on an extensive and far-reaching international network among wholesalers, large discounting retailers, and supermarkets. Moreover, it focuses on entry into the e-commerce space to reach households directly through subscription orders.

Bemax’s commitment is to the marketing, distribution, and delivery of high quality disposable baby diapers and wipes to respective target markets. Its present focus is to supply its clients with disposable baby diapers from manufacturers in North America where quality is superior.

Bemax is pursuing opportunities in the fast-growing worldwide Consumer Staples and Household Products Industries. The Company centers on business development and mentoring. It synergizes these models into the household products industry.

Last year, Bemax announced that it entered into a multi-year private labeling agreement with North American Diaper Company (NADC). With the agreement, Bemax will buy, sell, export, and distribute Mother's Touch disposable diapers in private labeled format and in Bemax packaging not trademarked by NADC. NADC is a leading U.S. manufacturer of value-priced, eco-friendly disposable baby diapers. Bemax is also extending its sales network to the Indian market.

At the end of April, Bemax announced that it filed for trademark with the U.S. Patent & Trademark Office (USPTO) for its brand of Mother's Touch disposable diapers. Bemax took this action as part of its overall international growth strategy to protect existing and upcoming private label brand identities, products, and services. It officially filed for trademark on April 28, 2018 (Serial Number 87899104).

Recently, Bemax announce that its private label brands of sanitary pads and baby wipes will be available for sales beginning September 11, 2018. The new Bemax private label brands will be available on Walmart.com and on bemaxinc.com/webstore.

Bemax, Inc. (BMXC), closed Thursday's trading session at $0.0003, up 50.00%, on 2,611,818 volume with 9 trades. The average volume for the last 3 months is 7,459,854 and the stock's 52-week low/high is $0.0002/$0.0041.

chart

Elixinol Global Limited (ELLXF)

Penny Stock Hub, Proactive Investors, Stock Target Advisor, Market Screener, TradingView, Stockhouse, Morningstar, Dividend Investor, Barchart, MarketWatch, 4-Traders, New Cannabis Ventures, Wallet Investors, and InvestorsHub reported on Elixinol Global Limited (ELLXF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Elixinol Global Limited is an international company operating in the industrial hemp, dietary supplements and developing medicinal cannabis sectors. The Company, via its businesses, has a worldwide presence in the cannabis industry. This includes hemp-derived CBD dietary supplements, hemp food and wellness products, and the cultivation and manufacture of medicinal cannabis products. Elixinol Global is headquartered in Sydney, Australia.

In September, Elixinol Global announced that it started trading on the “OTCQX Best Market” in the U.S. under the symbol “ELLXF,” as of September 18, 2018.  The OTCQX trading will operate in parallel to Elixinol Global’s ASX listing where the Company trades under ticker code EXL.

Elixinol Global’s businesses include Elixinol USA, Hemp Foods Australia and Elixinol Australia. Elixinol USA (established in 2014) is a manufacturer and international distributor of industrial hemp based dietary supplement and skincare products. Elixinol USA has operations based out of Colorado.

Elixinol USA is a CBD-based dietary supplements products business with
A$13.3m Revenues in Fiscal Year (FY) 2017. It has products now selling in the United States and 40 countries.

Hemp Foods Australia (established in 1999) is a foremost hemp food wholesaler, retailer, manufacturer and exporter of bulk and branded raw materials, and finished products. Hemp Foods Australia is the largest hemp foods provider in Australia with $3.2m Revenues in FY 2017.

Elixinol Australia was established in 2014 to participate in the developing Australian medicinal cannabis market. It has applications pending for cultivation and manufacturing licenses.

Last week, Elixinol Global announced that it successfully completed a placement to domestic and international institutional and sophisticated investors raising A$40 million at A$1.85 per share (Placement). This represents a 3.3 percent discount to the 15 day Volume Weighted Average Price (VWAP) of $1.91.

In the United States, Elixinol Global will apply funds towards increasing the capacity of its hemp-derived CBD production facility to prepare for rising levels of demand.  Elixinol will ramp up its sales force and marketing efforts in the United States and Europe. Additionally, the funds will provide the Company with more working capital to support its growth, pursue strategic investment opportunities and build its Australian medicinal cannabis facility, upon receipt of a Medicinal Cannabis license from the Office of Drug Control.

Elixinol Global Limited (ELLXF), closed Thursday's trading session at $1.45, up 2.11%, on 92,150 volume with 78 trades. The average volume for the last 3 months is 40,833 and the stock's 52-week low/high is $0.95/$1.95.

chart

Grupo TMM, S.A.B. (GTMAY)

Stockhouse, Penny Stock Tweets, Marketbeat, The Street, OTC Markets, Penny Stock Picks, Zacks, CapitalCube, YCharts, Wallet Investor, Amigo Bulls, Last10k, TradingView, Stockwatch, and VentureLine reported on Grupo TMM, S.A.B. (GTMAY), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Grupo TMM, S.A.B. is a Mexican Maritime-management transportation and logistics Company. Grupo TMM operates together with its subsidiaries in Mexico. The Company operates in four segments. These are Maritime, Logistics, Ports and Terminals, and Warehousing. Grupo TMM has its corporate headquarters in Mexico City, Mexico. The Company’s shares trade on the OTC Markets Group’s OTCQB.

As of March 31, 2018, Grupo TMM operated via a fleet of 39 vessels. These include product and chemical tankers, harbor tugs, and different offshore supply vessels.

Grupo TMM provides maritime transportation services. This includes offshore vessels that provide transportation and other services to the Mexican offshore oil industry. The Company also provides tankers that transport petroleum products in Mexican waters; parcel tankers that transport liquid chemical and vegetable oil cargos from and to the U.S. and Mexico; and tugboats that provide towing services at the port of Manzanillo, Mexico.

Additionally, Grupo TMM provides dry bulk carriers, which transport unpackaged commodities, including steel between South America, the Caribbean, and Mexico. It also provides ship repair services by way of two floating drydocks.

The Company also provides port agent services to vessel owners and operators in Mexican ports; and warehousing and bonded warehousing facility management services. Furthermore, it operates the Tuxpan, Tampico, and Acapulco port facilities.

Grupo TMM also offers logistics services; logistics network analysis; logistics information process design; intermodal transport; and supply chain and logistics management. The Company additionally offers product handling and repackaging; local pre-assembly; container maintenance and repair; and inbound and outbound distribution to automobile manufacturers and retailers.

In late April of this year, Grupo TMM reported its financial results for Q1 2018. Consolidated Revenues were $386.8 million, versus $509.3 million in Q1 of 2017.

The 2017 Q1 included the Revenues from TMM Division Maritima (TMMDM) that, as a result of Grupo TMM’s corporate reorganization in December 2017, was deconsolidated from Grupo TMM. Year over year, Ports and Terminals Revenue improved 25.0 percent. Moreover, Warehousing Services Revenues grew 25.2 percent in the 2018 Q1.

Consolidated Operating Profit was $17.8 million versus a loss of $32.9 million in the 2017 Q1.  The 2017 Q1 included the Operating Profit from TMMDM. Year over year, operating results in all divisions improved in Q1 of 2018.

Grupo TMM, S.A.B. (GTMAY), closed Thursday's trading session at $1.76, up 1.15%, on 3,010 volume with 1 trade. The average volume for the last 3 months is 3,020 and the stock's 52-week low/high is $0.59/$1.78.

chart

MedMen Enterprises, Inc. (MMNFF)

OTC Markets, Penny Stock Hub, OTC Stock Watch, Stockhouse, 4-Traders, Morningstar, Insider Financial, MarketWatch, Daily Marijuana Observer, Investors Hangout, The Street, Wallmine, TradingView, Barchart, Stockwatch, OTC Stock Picks, New Cannabis Ventures, Investing News, and GuruFocus reported on MedMen Enterprises, Inc. (MMNFF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

MedMen Enterprises, Inc. brings expertise and capital to the cannabis industry. The Company is one of the nation’s largest financial supporters of progressive marijuana laws. MedMen Enterprises owns and operates 18 facilities encompassing the entire vertical from cultivation to manufacturing to retail in three key states - California, Nevada and New York.

The Company has its corporate headquarters in Los Angeles, California. On May 29, 2018, MedMen Enterprises became a publicly traded company by way of a reverse takeover, or RTO. The Company’s shares trade on the OTC Markets Group’s OTCQB. MedMen enterprises has more than 800 employees.

MedMen’s professional team consists of cannabis experts, retail experts, marketing experts, financing experts, regulatory affairs experts, and agricultural and operations experts. The Company manages class leading retail stores that sell marijuana and marijuana products.

MedMen Enterprises operates a number of dispensaries in the most strategic markets in the nation. It has a fast-growing footprint that includes expansion plans in other important states as well as Canada.

Recently, MedMen Enterprises announced that it added ground cannabis flower to its product offerings in the State of New York. At present, MedMen stores in New York offer vaporizer pens, tinctures and gel caps in five different formulations. The addition of ground flower will give the Company’s New York medical marijuana patients more product choices in the State’s fast developing market.

Last week, MedMen Enterprises announced the upcoming opening of its marquee location in the heart of Downtown Las Vegas, Nevada. MedMen Enterprises has a total of three stores now planned for Las Vegas. This includes one on Paradise Road, near the Hard Rock Hotel and the Las Vegas International Airport, which won county approval recently.

MedMen Enterprises recently announced its expansion into a fourth key market, Florida, via a proposed acquisition of dispensary and cultivation assets from Treadwell Simpson Partnership and affiliates.

MedMen Enterprises, Inc. (MMNFF), closed Thursday's trading session at $4.1355, down 0.35%, on 694,445 volume with 1,524 trades. The average volume for the last 3 months is 695,440 and the stock's 52-week low/high is $2.61/$5.45.

chart

The QualityStocks Company Corner

Youngevity International, Inc. (NASDAQ: YGYI)

The QualityStocks Daily Newsletter would like to spotlight Youngevity International, Inc. (YGYI).

Youngevity International, Inc. (YGYI), a leading omni-direct lifestyle company, has announced the expansion of its HEMPFX line with the launch of two new hemp-derived cannabidiol products: HempFX™ Hydration™ – Sleep and HempFX™ Hydration™ – Pure. Both products are expected to be available in November of this year.

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.

Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.

Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.

Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.

Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:

  • Health and Nutrition
  • Home and Family
  • Food and Beverage
  • Spa and Beauty
  • Fashion
  • Essential Oils
  • Photo and scrapbooking
  • Services for Home and Business

Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.

Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.

Youngevity International, Inc. (NASDAQ: YGYI), closed the day's trading session at $8.07, up 19.38%, on 951,999 volume with 4,682 trades. The average volume for the last 3 months is 56,431 and the stock's 52-week low/high is $3.167/$7.973.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), which owns the patented DehydraTECH ingestion technology platform, is building its strategic intellectual property (IP) portfolio and plans to grow its patent applications to 150-200 worldwide within two years (http://nnw.fm/na2R0). Also today, CannabisNewsWire released a report on the company detailing how LXRP is one of the leaders in the world of cannabis, with applications made for more than 50 different patents and more to come.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body’s gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria’s products and others on the market is the company’s disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the “unusual” taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria’s processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company’s patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria’s lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world’s most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $2.05, up 13.92%, on 643,779 volume with 710 trades. The average volume for the last 3 months is 204,317 and the stock's 52-week low/high is $0.322/$2.54.

Recent News

chart

PreveCeutical Medical Inc. (CSE: PREV) (OTC: PRVCF) (FSE: 18H)

The QualityStocks Daily Newsletter would like to spotlight PreveCeutical Medical Inc. (PRVCF).

Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) late Wednesday announced its entry into a letter of intent with Penta 5 Packaging Inc. and Penta 5 USA, LLC (together the “Penta 5 Group”) through which PreveCeutical intends to acquire the Penta 5 Group and its assets, including over 120 market-ready products and a 150,000-square-foot, state-of-the-art packaging facility. To view the full press release, visit: http://nnw.fm/n9Jhh.

PreveCeutical Medical Inc. (CSE: PREV) (OTC: PRVCF) (FSE:18H), headquartered in Vancouver, British Columbia, Canada, is a health sciences company dedicated to researching and developing innovative options for preventive and curative therapies utilizing organic and Nature Identical™ products. The company is strategically staking out select positions in the medically acute areas of diabetes and obesity, pain management, neurological disorders and cancer.

PreveCeutical Medical Inc. had its beginnings in 2009 when Stephen Van Deventer, a seasoned businessman and venture capitalist, and Kimberly Van Deventer, a successful entrepreneur, met and formed a business partnership. The duo created Cornerstone Global Partners, a venture capital and business development company, and became involved in numerous ventures including building companies such as Aurora Cannabis Inc. Taking their interest in the health and wellness market further, the pair began researching how nature and science can work together to benefit health-conscious consumers. Coining and trademarking the word “PreveCeutical” – a combination of the words “preventive” and “pharmaceutical” – was a precursor to the company’s formation and incorporation in October 2015.

The company’s first product was developed in the Dominican Republic and is now marketed and distributed worldwide by PreveCeutical. It is a Caribbean Blue Scorpion venom product sold under the trade name CELLB9®. This product is an oral dilute solution infused with select peptides sourced exclusively from the blue scorpion (Rhopalurus princeps) found only in Caribbean nations. The active potentiated ingredients in CELLB9, which have been used in over 40 countries for over a decade, appear to support health at a deep, cellular level. PreveCeutical’s research team is using proprietary chemistry to generate Nature Identical™ peptides derived from natural compounds found in Caribbean Blue Scorpion venom with the goal of eventually treating, regulating and preventing cancer progression. Peptides are also being used to target an array of disease indications including metabolic disorders, pain management, cancers, cardiovascular and infectious diseases.

PreveCeutical is developing the first nose-to-brain delivery system of cannabinoids (CBDs) with a novel process that prepares insoluble drug-containing nano-micelles and successfully incorporating them into a proprietary sol-gels application, essentially creating a targeted drug delivery vehicle. Intended for use via a nasal spray, this unique formulation rapidly gels upon contact with mucosal tissue, which paves the way for direct nose-to-brain delivery. This novel application eliminates first pass metabolism (stomach, intestines, liver), potentially improving bioavailability and delivering extended time release formulations that may alleviate side effects of higher dosage therapeutics. This CBD-based patented formula is projected to be deployed in selected markets with licensed medical marijuana companies within 18 months.

PreveCeutical is working with four leading Australian research centers to develop a curative therapy for diabetes and obesity. This four-year program involves engineering a novel approach that selectively targets the gene that encodes for the protein PTP-1B, which is implicated and over-expressed in both type-2 diabetes and obesity. PreveCeutical’s gene-silencing technology would effectively “turn off” the genetic signal which leads to the over-production of this key protein molecule, bringing it back down to safe, normalized levels, and prevent the body from storing excessive fat. Diabetes kills one person every six seconds, with more than $800 billion spent globally on the disease.

Another exciting joint venture, established with Sports 1 Marketing, will focus on the therapeutic potential in the peptides and proteins connected to the Caribbean Blue Scorpion venom to potentially treat mild brain injury concussions. Developing a therapeutic product geared towards athletes who suffer from concussions could help alleviate suffering experienced by those who are affected by head trauma.

PreveCeutical Medical’s science and research team is led by Dr. Harendra (Harry) Parekh, Ph.D., who is based at the University of Queensland’s (UQ) Pharmacy Australia Centre of Excellence (PACE), and Dr. Makarand Jawadekar, Ph.D., whose 28 years of R&D experience with Pfizer Inc., is applicable in his role as chief science officer. Research collaborators include Dr. Rakesh Veedu, an emerging expert internationally in the field of molecular medicine, and Professor Grant Ramm, who is currently head of a leading medical research institute located in Brisbane, Australia.

PreveCeutical Medical is partnering with leading industry experts and companies in its quest to be a leader in the preventive health sciences sector. Its Research and Development partnership with UniQuest, the main commercialization company for the University of Queensland, provides PreveCeutical with the rights to all intellectual property arising from projects created under the agreement. PreveCeutical Medical Inc.’s management team brings an extensive portfolio of research experience, product development, deep corporate strategy and capital markets leadership to the company’s core.

PreveCeutical Medical Inc. (PRVCF), closed the day's trading session at $0.107, up 7.00%, on 1,031,663 volume with 185 trades. The average volume for the last 3 months is 902,486 and the stock's 52-week low/high is $0.002/$0.20.

Recent News

chart

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ)

The QualityStocks Daily Newsletter would like to spotlight QMC Quantum Minerals Corp. (QMCQF).

NetworkNewsAudio announces the Audio Press Release (APR) titled “The Lithium Boom Has Only Just Begun,” featuring Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ). To hear the NetworkNewsAudio version, visit: http://nnw.fm/arTY1. To read the full editorial, visit: http://nnw.fm/zgLP1.

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ) is a British Columbia based company engaged in the business of acquisition, exploration and development of natural resource properties. QMC’s focus is on creating shareholder value through strategic acquisition and development of high quality lithium, silver, gold, nickel, copper and zinc prospects.

QMC’s current properties are in the Canadian province of Manitoba, one of Canada’s most productive, centrally located mining regions. These resources include the Irgon Lithium Mine project and two Volcanic Massive Sulphide (“VMS”) properties – the Rocky Lake and Rocky-Namew known collectively as the Namew Lake District Project – which contain base metal-rich mineral deposits. Excellent access and well-developed mining infrastructure to the company’s wholly-owned Irgon Lithium Mine Project offers significant value and ramps up the near-term production schedule, putting QMC in a position to take advantage of rising lithium prices.

The region’s historic resource estimate of lithium is well documented in a 1956 Assessment Report developed by a previous owner, Lithium Corporation of Canada Ltd. The project’s historical resource estimate of 1.2 million tons grading 1.51% lithium-oxide over a strike length of 365 meters and to a depth of 213 meters is being updated by QMC through a detailed channel sampling and subsequent drill program.

North Face Software Ltd. recently created an interactive 3-D model of the Irgon Dike utilizing all historical data derived from past drilling and underground work. The 3-D model clearly demonstrates that exploration and underground development has only taken place on the central portion of the dike, leaving significant potential to quickly increase tonnage.

The company’s latest assay results, obtained from 144 channel samples at QMC’s Irgon Lithium Mine Project, provided encouraging and positive results that compare favorably with the historic assays. QMC has received a drill permit from the Sustainable Development Office of the Manitoba government and is in the process of requesting and assessing bids from drilling contractors. The company plans to begin a 2,000-meter drill program to confirm the historic lithium oxide assay results documented in the historic 1953-54 drill program.

QMC’s experienced leadership team includes specialists in mineral exploration, geology, engineering, new business development, marketing and investor relations. The company’s team of qualified advisors includes consultant Bruce E. Goad, P.Geo., who has 40 years of experience in mineral exploration in Canada, Argentina, Asia and Africa. As a Qualified Person, Goad has worked on numerous deposit styles including rare element pegmatites, porphyry, banded iron formation (BIF) gold deposits, skarn, greisens,  and VMS. He has a wide and varied skill set which includes precious, base, industrial and rare metal projects with a sharp focus on gold exploration. Goad is the author of several scholarly publications on pegmatite granites of the southeastern Manitoba region.

The market for lithium has surged over the past three years with prices per metric ton tripling. The world’s rising demand for portable power can easily been seen in the electric vehicle and mobile device industries – both of which use lithium-based, renewable batteries as a power resource. QMC’s high potential prospects and experienced management team, both in geology and corporate finance, put QMC and its shareholders in an excellent position to take advantage of the lithium, precious and base metals markets.

QMC Quantum Minerals Corp. (QMCQF), closed the day's trading session at $0.26, up 3.13%, on 156,294 volume with 57 trades. The average volume for the last 3 months is 110,183 and the stock's 52-week low/high is $0.129/$1.46.

Recent News

chart

Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

In Russia, cash on delivery is not just a way to pay for takeout; it’s how over 80 percent of online purchases are remunerated, according to Ecommerce News Europe (http://nnw.fm/XeJw8). However, that is changing fast. In 2017, “financial cards and payments performed positively in Russia”, says Euromonitor International (http://nnw.fm/G9M4u). Russian consumers are changing their purchasing habits, it seems, as financial literacy and cashless payment solutions, like those offered by Net Element, Inc. (NASDAQ: NETE), come to market.

Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

Net Element has also launched a new blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”

Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jeffrey Ginsburg, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed the day's trading session at $4.68, off by 0.43%, on 42,157 volume with 261 trades. The average volume for the last 3 months is 97,676 and the stock's 52-week low/high is $3.47/$33.51.

Recent News

chart

BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT)

The QualityStocks Daily Newsletter would like to spotlight BriaCell Therapeutics Corp. (BCTXF).

NetworkNewsAudio announces the Audio Press Release (APR) titled “Personalized Immunotherapy Could Be the Future for Advanced Breast Cancer Treatment,” featuring BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT). To hear the NetworkNewsAudio version, visit: http://nnw.fm/0UHqY. To read the full editorial, visit: http://nnw.fm/Ixnq5.

BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT), based in Berkeley, CA, and headquartered in Vancouver, British Columbia, is a clinical-stage biotechnology company focused on the development of targeted immunotherapy for advanced breast cancer.

BriaCell hopes to develop and market the first off-the-shelf personalized immunotherapy for the treatment of advanced breast cancer.

The results of two previous proof-of-concept clinical trials produced encouraging results in patients with advanced breast cancer. Most notably, one patient with breast cancer that had spread to other sites (metastatic cancer) responded to Bria-IMT™ with a substantial tumor shrinkage in multiple sites including the breast, the lung, soft tissues and even the brain. Similar observations have been confirmed more recently in additional patients, and BriaCell is developing BriaDX™ as a way to identify those patients most likely to respond.

BriaCell has recently completed recruitment of a Phase I/II study (NCT03066947) of Bria-IMT™, the Company’s lead product candidate, in advanced breast cancer patients showing an outstanding safety profile and excellent efficacy. BriaCell is currently enrolling advanced breast cancer patients in a combination therapy trial (NCT03328026) of Bria-IMT™ with Keytruda® (Keytruda® is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.) or Yervoy® (Yervoy® is a registered trademark of Bristol-Myers Squibb Company). For further information on the Phase IIa clinical trials, please visit trial NCT03066947 and trial NCT03328026.

BriaCell’s pipeline also includes Bria-OTS™, the first off-the-shelf personalized immunotherapy for advanced breast cancer; and, a companion diagnostic product BriaDX™. By using BriaDX™ to identify and treat the patients who would most likely benefit from their immunotherapies, BriaCell expects to personalize the treatment for the patients, and bring hope to thousands of cancer patients who currently have few-to-no treatment options.

Breast Cancer Statistics

The National Cancer Institute estimates that more than 265,000 new cases of female breast cancer will be diagnosed in the U.S. during 2018, and that more than 40,000 women in the U.S. will die from the disease. Approximately 12 percent of women will be diagnosed with breast cancer at some point during their lifetime, based on 2013-2015 data.

Using its novel technology platform and strong R&D capabilities, BriaCell believes it has the opportunity to address this market, as well as have the opportunity to develop immunotherapy candidates for other cancer indications.

The global cancer immunotherapy market is expected to reach nearly USD$203 billion by 2025.

BriaCell Therapeutics Corp. (BCTXF), closed the day's trading session at $0.0938, off by 2.29%, on 12,066 volume with 4 trades. The average volume for the last 3 months is 15,284 and the stock's 52-week low/high is $0.068/$1.14.

Recent News

chart

The Flowr Corporation (TSX.V: FLWR)

The QualityStocks Daily Newsletter would like to spotlight The Flowr Corporation (FLWR).

The Flowr Corporation (TSX.V: FLWR), a vertically integrated Canadian cannabis company, was the subject of an article published by TheGlobeandMail.com today, titled ‘Cannabis Professional: Ace Hill, Flowr blaze the branding trail with licensing deal’ authored by Mark Rendell. To view the full article, visit: http://cnw.fm/bsE7S. Also today, NetworkNewsWire released a report on the company detailing how FLWR has appointed Francesco Tallarico as general counsel and corporate secretary, effective October 1, 2018. To view the full press release, visit: http://nnw.fm/0qPau.

The Flowr Corporation (TSX.V: FLWR), a Health Canada Licensed Producer (LP) of cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR), is an emerging Canadian cannabis leader founded by Medreleaf co-founder Tom Flow and a team of industry pioneers, successful start-up executives and top industry scientists. Flowr’s purpose-built cultivation facilities may be the most advanced in the industry, consistently generating high crop yields, delivering premium and ultra-premium cannabis products, and maximizing return on investment. The company also may be an R&D leader as it was selected by the Hawthorne Gardening Division of The Scotts Miracle-Gro Company as its exclusive Canadian cannabis R&D partner.

Flowr’s flagship facility, an 84,000-square-foot campus on seven acres in Kelowna, British Columbia, is engineered to grow premium cannabis in rooms that meet pharmaceutical industry production standards for cleanliness. This, along with exacting protocols designed by the Flowr team, enables Flowr to grow cannabis that meets Health Canada’s stringent standards without treating it with the taste- and smell-killing gamma irradiation that most other producers have to use to clean their product. Irradiating the plant – a process similar to pasteurizing food – impairs many of the important terpenes that provide the positive effects, flavors and scents of cannabis while strengthening unpleasant terpenes. Flowr’s products may deliver a better user experience, thus commanding premium prices.

Flowr’s cultivation facilities, built with proprietary, patent-pending systems, are designed to deliver yields targeted at 450 grams per square foot by the end of 2022, which is three times more efficient than the industry average of approximately 150 grams per square foot. By optimizing yield, the Company may produce significantly more cannabis flower on a smaller footprint than other producers, thus generating far high revenue per square foot and keeping costs much lower, leading to higher margins. The Kelowna facility is presently 20 percent operational with the remaining 80 percent slated to come online by early 2019. It is expected to produce up to 14,000 kg of premium, non-irradiated cannabis flower in 2019. With further enhanced yields and planned expansion of production facilities on the campus, Flowr will reach a total capacity of 60,000 kg annually in 2022.

Leading Flowr’s cultivation program is industry pioneer, company co-founder and Flowr president Tom Flow. Flow is widely recognized for his cannabis thought leadership and expertise building and operating cannabis cultivation facilities. Flow also co-founded MedReleaf and designed, built and set up SOPs for their flagship Marcum cultivation facility. Marcum has continued to be perhaps the most productive facility in the country prior to the Flowr flagship facility. Long one of Canada’s most efficient and profitable LPs, MedReleaf was acquired by Aurora for approximately C$3 billion. Flow and his team have designed and built a total of 17 cultivation facilities and secured three producer’s licenses under various Canadian regulatory regimes.

In March 2018, Flowr and the Hawthorne Gardening Division of The Scotts Miracle-Gro Company – a world leader in lawn and garden products – announced an exclusive strategic R&D alliance. After evaluating numerous Canadian LPs, Hawthorne chose to partner with Flowr based on the experience and expertise of the company’s cultivation and R&D teams and the company’s advanced growing capabilities.

Hawthorne will fund the construction of a 50,000-square-foot R&D facility that is integrated into Flowr’s Kelowna campus. This facility is North America’s first dedicated cannabis R&D facility focused on advancing cultivation techniques and systems. The facility will support researchers from both organizations and combine laboratories, indoor and greenhouse grow suites, training areas and genetics breeding areas in a single building. It is expected to open in early 2019. In addition to helping Flowr maintain its competitive advantage in cultivation, the company’s R&D program will keep it on the cutting edge of cannabis innovation.

Flowr is entering the market with three different brands to meet the growing demand for premium, non-irradiated cannabis in the medicinal and adult use markets:

  • FlowrRx, featuring premium quality medicinal cannabis that enables patients to live better, fuller lives. A dedicated Client Services team will provide patients with personalized support while an R&D team develops innovative flower strains and premium products targeted to specific conditions. Patient well-being is considered at every stage of the process – from genetic selection to harvest, trimming and curing techniques. FlowrRx and its team of passionate scientists and leading cultivation specialists are dedicated to advancing the scientific understanding of cannabis.
  • Flowr is the company’s premium recreational adult-use brand featuring an active, West Coast-inspired lifestyle for the cannabis connoisseur and enthusiast market. Through the continuous innovation of procedures and practices, Flowr’s talented team of experts is crafting premium products that deliver unparalleled experiences.
  • Ace Valley, an exclusive partnership with top-selling Ontario craft beer company Ace Hill, will bring Flowr’s premium product to the millennial and casual adult-use markets under the Ace Valley brand.

Flowr recently signed a Memorandum of Understanding with the British Columbia Liquor Distribution Branch, the province’s sole legal wholesaler of non-medical cannabis, to supply premium and ultra-premium flower to the province’s retail outlets. The company has agreements with several major medical distributors and is in discussions about retail distribution with additional provinces where it believes it can obtain prices commensurate with the quality of the Flowr products. The company is also evaluating other market opportunities including export.

Flowr is poised to become the pre-eminent indoor premium cannabis grower in Canada and one of the country’s top five LPs. The company’s focus on yield, quality and price point and its team’s ability to grow at scale should drive high margins, significant growth and strong return on investment.

The Flowr Corporation (TSX.V: FLWR), closed the day's trading session at $6.03, up 0.50%, on 104,816 volume with 218 trades. The average volume for the last 3 months is 251,441 and the stock's 52-week low/high is $4.00/$8.00.

Recent News

chart

DeepMarkit Inc. (TSX-V: MKT) (OTC: MKTDF)

The QualityStocks Daily Newsletter would like to spotlight DeepMarkit Inc. (MKTDF).

Traditional mass media channels are becoming less appealing for companies to spend their marketing budgets on as audiences are daily increasing their ability to optimize the content they see. Social media platforms are constantly updating algorithms and changing the rules by which businesses engage with customers. So where does this leave today’s forward-thinking marketing team? DeepMarkit Corp. (TSX.V: MKT) (OTCQB: MKTDF) is working to help businesses engage consumers and other audiences with gamification. Also today, NetworkNewsWire released a report on the company detailing how MKTDF is engaged in the incorporation of game elements into marketing, also known as Gamification. To view the full article, visit: http://nnw.fm/2vzIJ.

DeepMarkit Inc. (TSX-V: MKT) (OTC: MKTDF), based in Calgary, Alberta, Canada, is a patent pending gamification technology company inventing new ways to engage consumers and other audiences. The Company’s proprietary promotions platform – “Gamify” – enables businesses and agencies to create branded games that incentivize consumers, thus driving sales, capturing data and generating leads. The DeepMarkit platform integrates next-gen gamification engagement mechanics with interactive advertising industry standards and powerful visuals, including 3-D images. Customers may choose from both free and paid solutions suitable for campaigns of all sizes, targeting multiple channels on the web, mobile and social media.

A team of seasoned, passionate gaming executives, led by president and CEO Darold Parken, has worked together for more than 15 years developing games and gaming systems that are still used today by some of the largest gaming companies in the world. This accomplished executive team founded Chartwell Technologies, acquired in 2011 by Amaya Gaming, which now is known as The Stars Group (Nasdaq: TSG) with a market cap of over $5 billion.

Gamify offers a selection of easily customizable gaming apps featuring a customer’s branded e-store in addition to tailored landing pages, technical support, real-time analytics, data collection and an engaging marketing campaign. Gamify’s patent-pending app comes complete with unique user incentives that draw consumers in with games and prizes, which in turn engages shoppers, turning them into buyers and building brand loyalty.

The gamification market is rapidly expanding and projected to be worth $22 billion by 2022, with a CAGR of 41 percent. DeepMarkit is the only publicly listed company focused solely on this exploding market that embraces any size of business, from the mom-and-pop shops to the blue-chip giants. DeepMarkit’s management team knows that increasing a customer’s conversion rate by a mere 1 percent has the potential to double revenue, which is why Gamify’s app and its ability to transform simple shoppers into engaged buyers is so compelling.

“Our marketing platform enables customers to build branded games that incentivize audiences, generate leads, and drive sales. Businesses need a way to stand out from the crowd,” Parken states in an investor’s video (https://www.youtube.com/watch?v=97hJoRKR92k). “DeepMarkit’s gamification platform gives customers that way to stand out and it’s a way that they can afford. That’s the strength of our platform. For a relatively small amount of money, any business can create a very powerful, high quality customer engagement using gamification.”

DeepMarkit recently entered into a joint marketing agreement with ITN International (“ITN”), a global leader in trade show data capture and analytics. The agreement will enable the 1.5 million exhibitors at the 125-plus yearly events serviced by ITN to purchase a customizable campaign with prize delivery and branded games that can be used in collaboration with ITN’s lead retrieval solutions. DeepMarkit and ITN are currently integrating DeepMarkit’s patent-pending gamification platform directly into ITN’s exhibitor portal.

“We started DeepMarkit because we have a passion for games and we believe in the power of games, not just for entertainment but more importantly as a tool for business,” Parken said. “DeepMarkit is a gamification company. What we mean by that is that we create innovative ways to use games for business purposes. Games to generate customer leads, games to promote products, deliver rewards, build brand awareness and customer loyalty.”

Selected as the winner of the New Company/Product pitch competition at the Retail Global 2017 Conference held in Las Vegas, Gamify’s platform has also attracted a $1.5 million investment from Allstate International LLC in Hong Kong. The investment gives Allstate a 10 percent stake in DeepMarkit and a great opportunity to bring the Gamify platform into the burgeoning Asian gaming market.

DeepMarkit Inc. (MKTDF), closed the day's trading session at $0.0209, even for the day, on 300,000 volume with 8 trades. The average volume for the last 3 months is 30,212 and the stock's 52-week low/high is $0.0195/$0.1199.

Recent News

chart

DPW Holdings, Inc. (NYSE American: DPW)

The QualityStocks Daily Newsletter would like to spotlight DPW Holdings, Inc. (DPW).

DPW Holdings, Inc. (NYSE American: DPW) (“DPW”), a diversified holding company, today announced that its subsidiary Super Crypto Mining entered into a Revolving Loan Agreement for up to $2.5 million and in connection with a Security Agreement granting interest in certain collateral, including bitcoin.

DPW Holdings, Inc. (NYSE American: DPW), is a diverse holding company pursuing a growth strategy of  acquiring undervalued assets with disruptive technologies with a global impact.

The company invests in diverse industries within the commercial, defense/aerospace, industrial, communication, medical, crypto-mining, hospitality, textile, and corporate investment/lending sectors. DPW has evolved and grown from being a leader in advanced power products. Through its subsidiaries, the company continues to be a leader and supplier of innovative technologies, advanced design and development services, and state-of-the-art power products and solutions.

Through its wholly owned Coolisys Technologies, Inc. subsidiary, DPW is committed to offering world-class technology-based solutions for critical applications and lifesaving services that are primarily driven by innovation. Coolisys targets to the defense, aerospace, naval, homeland security, medical, telecom, datacom and industrial markets. Its growth strategy centers on core markets that are characterized by “high barriers to entry” and require specialized products and services not likely to be commoditized. Through a portfolio of companies, Coolisys is engaged in developing and manufacturing advanced switching power products and power solutions that utilize a customized digital power management and resonant topology to attain:

  • The highest efficiency and highest density power converters and inverters
  • Specialized complex airborne high-frequency, radio frequency (RF), and microwave detector-log video amplifiers (DLVA)
  • Very high-frequency filters
  • Naval power conversion and distribution equipment

Coolisys offers its technology and services through three primary groups: the Power Solutions Group (PSG), the Defense and Aerospace Solutions Group (DSG), and the Advanced Service Industries (ASI) Group. Coolisys manages five divisions:

  • Digital Power Corporation, a leader in providing power electronics technology that is based in northern California.
  • Digital Power Limited dba Gresham Power Ltd, a designer and manufacturer of power distribution systems primarily for Naval use that is based in Salisbury, UK.
  • Microphase Corporation, a designer and manufacturer of microwave electronics technology that is based in Shelton, Connecticut.
  • Power-Plus Technical Distributors, a value-added distributor that is based in Sonora, California.
  • Enertec Systems, a developer and manufacturer of specialized advanced electronic systems for the defense and aerospace sectors that is based in Karmiel, Israel.

DPW’s portfolio of wholly owned subsidiaries also includes Digital Power Lending, LLC (DPL), a California private lending company operating under Financial Lender’s License ##60DBO-77905. DPL is dedicated to strategically providing capital to small and middle-size businesses for an equity interest in addition to loan fees and interest. DPL provides secured and unsecured debt financing for public and private companies. These loans will typically have a six to 12-month maturity and range from $250,000-$5 million. DPL is active in bridge loans, receivable financing, inter company loans and micro loans. DPL will work with a network of company owned ATMs (terminals) in California, which will help utilize its CA Finance Lending License and enable the company to offer micro loans of up to $500 or less.

Management has over 50 years of Wall Street experience of investing in, and building companies. DPL’s desire is to bring world-class companies lending opportunities while allowing main street investors to participate. Deal flow and organization comes from an extensive network of investment bankers, business brokers, family offices, and institutional clients enabling DPL to engage and fund the most compelling companies from Silicon Valley to Wall Street.

To date, DPL has funded over $19 million in loans. Since inception, DPL has internally funded over $15 million to DPW’s portfolio companies and wholly owned subsidiaries. As for companies outside DPW, DPL has lent over $4 million in commercial and real estate loans. DPL has funded INVO Bioscience, Medovex, Parallax, Alzamend Neuro, as well as hospitality clients, such as Guilia DTLA and Prep Kitchens.

Another subsidiary wholly owned by DPW is Super Crypto Mining, Inc., a cloud computing service that provides shared and managed computing resources optimized for various block chain mining solutions. Based in Newport Beach, California, Super Crypto Mining leverages its engineering expertise and existing locations to create cryptocurrency mining facilities throughout the world. The company owns and maintains the computing resources and sells access to their use. The established mining is on the Top 3 crypto-currencies with the goal of having 10,000 miners deployed in 2018. Super Crypto Mining endeavors to leverage its engineering expertise and existing global facilities (high-security defense business locations) to secure mining farms. Super Crypto Mining is a rapidly growing organization that recently strategically secured 25 mega watts to power the company’s mining farm. For crypto currency mining, locations with inexpensive power and secure capacity are minimal and hence costly. Having such a location allows the company to grow its mining business to more than 20,000 mining machines. Super Crypto Mining continues to purchase mining machines and explore opportunities to expand its services into other related areas including mining farm real estate investments, mining machine development, and mainstream blockchain projects.

DPW additionally has beneficiary ownership in MTIX International, Inc., the parent company of MTIX, Ltd. and I.AM, Inc.

MTIX was acquired by Avalanche International aka MTIX International, Inc., in August 2017 and offers “green technology” that uses a proprietary laser process to enhance the surface of textiles. This process reduces water usage by approximately 75 percent, reduces greenhouse gases by approximately 90 percent, and reduces chemical use by approximately 95 percent.

I.AM, acquired in May 2018, owns and operates hospitality offerings that include four Prep Kitchen brand restaurants and Giulia DTLA.

Utilizing a shareholder-centric approach to compensation, DPW has formulated the following 10-year objectives:

  • Achieve compounded annual revenue growth of 25-35%
  • Achieve compounded annual net Income growth of 5%
  • Achieve positive unrestricted free cash flow by the end of 2019

DPW is led by a seasoned team of successful business professionals and entrepreneurs. The company is headquartered in Newport Beach, California.

DPW Holdings, Inc. (DPW), closed the day's trading session at $0.4024, off by 1.85%, on 1,186,964 volume with 1,802 trades. The average volume for the last 3 months is 1,739,850 and the stock's 52-week low/high is $0.389/$5.95.

Recent News

chart

First Cobalt Corp. (TSX.V: FCC) (OTC: FTSSF)

The QualityStocks Daily Newsletter would like to spotlight First Cobalt Corp. (FTSSF).

First Cobalt Corp. (TSX-V: FCC; ASX: FCC; OTCQX: FTSSF) (the "Company") is pleased to announce drill results from its Iron Creek Cobalt Project in Idaho, USA. Results reported today highlight a high grade zone at the western extent of the current Inferred Resource, which remains open along strike and at depth. Also today, NetworkNewsWire released a report on the company detailing how the initial resource estimate and pace of progress at Iron Creek have exceeded the company’s expectations.

First Cobalt Corp. (TSX.V: FCC) (OTC: FTSSF), with headquarters in Canada, is the largest land owner in the Cobalt Camp in Ontario with control of over 10,000 hectares (nearly 25,000 acres) of prospective land and 50 historic cobalt/silver mines. The company’s assets include a mill and the only permitted cobalt extraction refinery in North America capable of producing battery material, providing an integrated solution for cobalt projects. First Cobalt began drilling in the historic Cobalt Camp in 2017 and seeks to build shareholder value through new discovery and growth opportunities.

First Cobalt’s 2018 $C7 million drilling program, which includes testing different styles of mineralized areas throughout the Cobalt Camp in more than 10 past-producing mines known to contain cobalt, is a significant expansion over its 2017 exploration activities. The company received positive test drill results from the Bellellen mine location, with early results confirming the presence of high-grade cobalt and nickel, prompting First Cobalt to increase its drilling program at that site. A prospecting sampling program of existing muckpiles around the camp’s historic mines, trenches, pits and surrounding bedrock could provide an early production scenario.

First Cobalt Corp. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world’s current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

First Cobalt is embracing innovation in the mining sector, utilizing a digital compilation of 100-plus years of mining and geological data spanning the historically prolific Cobalt Mining Camp’s lifespan. First Cobalt’s management team is also assessing the ability of artificial intelligence to accelerate the discovery cycle. As a member of the Mineral Exploration Research Centre (MERC) and Metal Earth Project, First Cobalt conducts regional geophysical surveys for geological interpretation of structures controlling cobalt-silver mineralization.

The company’s clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, First Cobalt Corp. and its mining interests are primed for success.

First Cobalt Corp. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance.

First Cobalt Corp. (FTSSF), closed the day's trading session at $0.245, off by 2.19%, on 287,014 volume with 68 trades. The average volume for the last 3 months is 206,915 and the stock's 52-week low/high is $0.1983/$1.3041.

Recent News

chart

Sunniva, Inc. (CSE: SNN) (OTC: SNNVF)

The QualityStocks Daily Newsletter would like to spotlight Sunniva, Inc. (SNNVF).

Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) was highlighted in an article today from CannabisNewsWire examining how Los Angeles International Airport announced that passengers were free to have cannabis on them or in their luggage when boarding flights as long as it didn’t exceed the amount allowed by California law. Currently, 28.5 grams or 8grams of concentrated cannabis (oil, for example) can be carried by someone within the state. This only applies to people who are 21-years of age or more.

Sunniva, Inc. (CSE: SNN) (OTC: SNNVF) is a vertically integrated medical cannabis company operating in the world’s two largest cannabis markets – Canada and California – committed to delivering safe, consistent, high-quality products and services. Sunniva operates through its wholly owned subsidiaries: Sunniva Medical Inc., CP Logistics, LLC, Natural Health Service Ltd., and Full-Scale Distributors, LLC. Sunniva’s vision is to become the lowest cost, highest quality cannabis producer in the markets it serves by building large scale purpose-built cGMP-compliant greenhouses, offering best quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education, and sourcing better therapeutic delivery devices.

The company is establishing sophisticated distribution channels, including Sunniva’s ownership of Natural Health Services cannabis clinics in Canada with over 95,000 active patients, to purchase the significant quantities of high quality Sunniva-branded and Sunniva private-labeled cannabis products.

Sunniva is an ancient English name which means, “Gift of the Sun.” Sunniva’s team of horticulturists, scientists and engineers is helping to set best practices for the industry, believing that sun-grown, solar-powered cultivation is the most sustainable and cost-effective way to grow high-quality, premium cannabis.

The Sunniva Family includes:

CP Logistics, LLC

Through its subsidiary, CP Logistics LLC, Sunniva is developing Sunniva Campus, a state-of-the-art, purpose-built greenhouse facility in Cathedral City, California. This modern purpose-built, agri-technology greenhouse will adhere to the Current Good Manufacturing Practice (cGMP) regulations that assure proper design, monitoring and control of manufacturing processes and facilities.

Phase 1 of the project includes a fully funded 325,000 square foot greenhouse capable of producing 60,000 kg per year of dry cannabis at capacity with operations commencing Q3 2018. Approximately 30 percent of initial total production will be converted into oils and extracts. Phase 2 is expected to increase the greenhouse by 165,000 square feet and grow production by about 40,000 kg per year.

These uniquely sealed greenhouses are designed to deploy custom, automation assembly line cultivation processes at a large scale. Energy consumption will be reduced while utilizing the energy of the sun and microclimatic controls to provide precise growing conditions. The greenhouse will recirculate air for more efficient climate control, and the company’s Integrated Pest Management System is designed to ensure every plant grown is certified clean and free of all contaminants and pesticides.

Sunniva Medical Inc.

Sunniva Medical Inc. is designing and preparing to break ground on the Sunniva Canada Campus encompassing 700,000 square feet of purpose-built cGMP greenhouse facilities in the Okanagan Valley, British Columbia. The total campus is expected to produce 100,000 kg of premium medical cannabis a year plus additional trim used for extraction. This facility will produce pesticide-free products and will convert trim to extracted products such as cannabis oil that can be used for drug delivery formats such as capsules, dissolvable strips, vaporization cartridges, tinctures and creams.

Sunniva and Canopy Growth Corporation (“Canopy Growth”) recently announced a large take or pay supply agreement. Under the terms of the agreement, Canopy Growth will purchase up to 45,000 kilograms of dried cannabis annually commencing Q1 2019, which includes the distribution of Sunniva branded products. Sunniva Medical is a late-stage applicant under Canada’s ACMPR and is in the final review stage of the process.

Natural Health Services Ltd.

Natural Health Services (“NHS”) owns and operates a network of eight medical clinics in Canada specializing in medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). NHS connects licensed producers to their 21 physicians and patients with its proprietary SPARK software which utilizes a software-as-a-service revenue model. To date, there are 27 integrated licensed producers utilizing the SPARK software.

In-house physicians specializing in the endocannabinoid system provide expert consultation, education and recommendations for targeted phytoceutical remedies and wellness plans to improve the quality of life for all patients. NHS enjoys a long-term relationship with patients due to the quality of its physician-patient experience. A rapidly expanding NHS cannabis clinic network serves 94,000 active patients in Canada. NHS has also initiated a pilot program with a national pharmacy chain to aggregate more patients.

Full-Scale Distributors, LLC

Full-Scale Distributors, LLC is an industry leading provider of custom, private-label vaporizers through its brand, Vapor Connoisseur. The company currently serves the needs of over 80 top brands in the North American marketplace. Vapor Connoisseur is recognized for its high quality and innovative therapeutic delivery devices. Products are tailored to client needs, ensuring both safety and reliability.

Sunniva’s highly experienced management team is building partnerships with leading scientists, universities and clinical trial groups to deliver proprietary cannabis formulations to a broad spectrum of health ailments and conditions. These global partners require cGMP-certified facilities for the processing and manufacturing of cannabis products. Sunniva is committed to providing safe, pesticide-free, high quality, reproducible cannabis medicines.

Leading Sunniva is co-founder, chairman and CEO Dr. Anthony (Tony) Holler. He is the former CEO and founder of ID Biomedical, which was acquired in 2005 for $1.7 billion by GlaxoSmithKline. He is also the former chairman of Corriente Resources Inc., which was sold for approximately $700 million to CRCC-Tongguan Investment Co. Holler is currently chairman of CRH Medical Corporation, a public company trading on the TSX and NYSE. His expertise includes strategic planning, mergers and acquisitions and financing with a singular focus on increasing shareholder value.

Holler is joined by co-founder Leith Pedersen, who serves as president of Sunniva. Pedersen is the former owner and CEO of Vida Wealth Management Bahamas and was a former investment advisor at Canaccord Wealth Management. He is a former partner and director at JF Mackie and Company, an independent brokerage firm in Calgary, Alberta, that managed capital in excess of $2 billion for high net worth clients. Pedersen’s expertise is in corporate strategy, financing and mergers and acquisitions.

Sunniva, Inc. (SNNVF), closed the day's trading session at $4.3338, up 3.43%, on 42,322 volume with 117 trades. The average volume for the last 3 months is 70,498 and the stock's 52-week low/high is $3.609/$16.00.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Sugarmade, Inc. (OTC: SGMD), a client of CNW focused on investment in products and brands with disruptive potential. To view the full publication, titled “Growing Cannabis Sector Sees Surge in Acquisitions,” visit: http://cnw.fm/QG4t3. Also today, the company was highlighted in a report by CannabisNewsWire examining how Los Angeles International Airport announced that passengers were free to have cannabis on them or in their luggage when boarding flights as long as it didn’t exceed the amount allowed by California law.

Sugarmade, Inc. (SGMD) one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.

Sugarmade, Inc. (SGMD), closed the day's trading session at $0.1198, up 0.67%, on 1,972,915 volume with 221 trades. The average volume for the last 3 months is 1,847,539 and the stock's 52-week low/high is $0.028/$0.13.

Recent News

chart

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)

The QualityStocks Daily Newsletter would like to spotlight VIVO Cannabis Inc. (VVCIF).

VIVO Cannabis Inc. (TSXV: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”) is pleased to announce that it has entered into an agreement with Pharmascience Inc. (“Pharmascience”), a global pharmaceutical company based in Montreal that holds a Dealers License from Health Canada, to develop products containing cannabis that will make it easier for patients to use medical cannabis. The partnership reflects VIVO’s commitment to research and innovation and its goal of creating novel products which improve the safety and efficacy of medical cannabis.

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.

“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.

VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.

VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.

This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.

VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.

VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.

Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.

VIVO Cannabis Inc. (VVCIF), closed the day's trading session at $1.10, off by 2.65%, on 409,508 volume with 526 trades. The average volume for the last 3 months is 649,951 and the stock's 52-week low/high is $0.73/$3.29.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

The growing mainstream popularity of blockchain-based payments is reflected in a recent TV advertisement by SinglePoint, Inc. (OTCQB: SING) for its cryptocurrency wallet. Also today, NetworkNewsWire released a report on the company detailing the recently signed distribution agreement with American Premium Water Corp. (OTC: HIPH).

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.0319, up 0.16%, on 3,076,233 volume with 183 trades. The average volume for the last 3 months is 4,233,355 and the stock's 52-week low/high is $0.0235/$0.133.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.